On 19 May 2025, Archer Materials Limited (ASX:AXE), an Australian semiconductor company advancing the quantum technology and medical diagnostics industries, announced a partnership with Paragraf to develop the Biochip, a potassium ion sensor for testing of chronic kidney disease built on Paragraf’s GMS platform. According to the agreement, work will be carried out in two stages, with each stage of work to be carried out over three months at a total estimated cost of £222,000.
The announcement garnered coverage from news outlets such as by Graphene-Info, TipRanks, SmallCaps and New Electronics.
The full text of the release can be found at 250519_AXE_partnership-with-Paragraf-FINAL.pdf.
To see for yourself how our GMS product can serve your molecular sensing needs, you can purchase a quad pack from Paragraf’s Online Store today.
